Opaleye Management’s Theravance Biopharma TBPH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-543,500
| Closed | -$5.63M | – | 52 |
|
|
2023
Q2 | $5.63M | Sell |
543,500
-2,804
| -0.5% | -$29K | 1.35% | 20 |
|
|
2023
Q1 | $5.93M | Buy |
546,304
+458,704
| +524% | +$4.98M | 1.78% | 16 |
|
|
2022
Q4 | $983K | Buy |
+87,600
| New | +$983K | 0.34% | 38 |
|
|
2017
Q4 | – | Sell |
-180,000
| Closed | -$6.16M | – | 41 |
|
|
2017
Q3 | $6.16M | Hold |
180,000
| – | – | 2.18% | 17 |
|
|
2017
Q2 | $7.17M | Hold |
180,000
| – | – | 3% | 9 |
|
|
2017
Q1 | $6.63M | Buy |
180,000
+21,800
| +14% | +$803K | 3.3% | 8 |
|
|
2016
Q4 | $5.04M | Buy |
+158,200
| New | +$5.04M | 2.97% | 11 |
|